General and modular strategy for designing potent, selective, and pharmacologically compliant inhibitors of rhomboid proteases Journal Article
| Authors: | Tichá, A.; Stanchev, S.; Vinothkumar, K. R.; Mikles, D. C.; Pachl, P.; Began, J.; Škerle, J.; Švehlová, K.; Nguyen, M. T. N.; Verhelst, S. H. L.; Johnson, D. C.; Bachovchin, D. A.; Lepšík, M.; Majer, P.; Strisovsky, K. |
| Article Title: | General and modular strategy for designing potent, selective, and pharmacologically compliant inhibitors of rhomboid proteases |
| Abstract: | Rhomboid-family intramembrane proteases regulate important biological processes and have been associated with malaria, cancer, and Parkinson's disease. However, due to the lack of potent, selective, and pharmacologically compliant inhibitors, the wide therapeutic potential of rhomboids is currently untapped. Here, we bridge this gap by discovering that peptidyl α-ketoamides substituted at the ketoamide nitrogen by hydrophobic groups are potent rhomboid inhibitors active in the nanomolar range, surpassing the currently used rhomboid inhibitors by up to three orders of magnitude. Such peptidyl ketoamides show selectivity for rhomboids, leaving most human serine hydrolases unaffected. Crystal structures show that these compounds bind the active site of rhomboid covalently and in a substrate-like manner, and kinetic analysis reveals their reversible, slow-binding, non-competitive mechanism. Since ketoamides are clinically used pharmacophores, our findings uncover a straightforward modular way for the design of specific inhibitors of rhomboid proteases, which can be widely applicable in cell biology and drug discovery. Ticha et al. discover rhomboid protease inhibitors that are unprecedentedly potent and selective. They are based on a pharmacologically compliant chemotype and can thus serve as hitherto unavailable specific tools for cell biology or can yield lead compounds targeting rhomboids in medically relevant contexts such as malaria or Parkinson's disease. © 2017 The Authors |
| Keywords: | inhibitor; crystal structure; mechanism; specificity; inhibition; intramembrane protease; rhomboid protease; ketoamide |
| Journal Title: | Cell Chemical Biology |
| Volume: | 24 |
| Issue: | 12 |
| ISSN: | 2451-9456 |
| Publisher: | Cell Press |
| Date Published: | 2017-12-21 |
| Start Page: | 1523 |
| End Page: | 1536.e4 |
| Language: | English |
| DOI: | 10.1016/j.chembiol.2017.09.007 |
| PROVIDER: | scopus |
| PMCID: | PMC5746060 |
| PUBMED: | 29107700 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 May 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
35Bachovchin -
14Johnson
Related MSK Work